Should human DNA be patentable? That's the central question in Association for Molecular Pathology v. Myriad Genetics, a case argued before the U.S. Supreme Court in April. The lawsuit was organized by the American Civil Liberties Union on behalf of several professional organizations that have long opposed such patents, which the U.S. Patent and Trademark Office has been granting since the 1980s. Patent law is arcane, and arguments about it can sound a lot like squabbling over the number of angels that can dance on the head of a pin. But in this case, writes Science Correspondent Ronald Bailey, it affects tens of billions of dollars in research, products, and profits.
Untested delta-8-THC products are gaining in popularity
Cases are rising mainly in states with stricter disease control policies.
Manhattan Will Drop Charges for Prostitution and Unlicensed Massage but Continue Prosecuting Prostitution Patrons
The Nordic Model comes to Manhattan.
"How can an ordinary person afford to wait years after the government takes their car?"
The Massachusetts Congresswoman is a two-time supporter of the Rent and Mortgage Cancelation Act.